Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter

Neuron

Volumn 19, Issue 1, 1997, Pages 127-138

  Bossé, Roger ^a   Fumagalli, Fabio ^a,b   Jaber, Mohamed ^a   Giros, Bruno ^a   Gainetdinov, Raul R ^a   Wetsel, William C ^a   Missale, Cristina ^a   Caron, Marc G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PROLACTIN;

ADENOHYPOPHYSIS HYPOFUNCTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; FEMALE; GENE DELETION; HYPOPLASIA; HYPOTHALAMUS; LACTATION DISORDER; MALE; MOUSE; NONHUMAN; PITUITARY DWARFISM; PRIORITY JOURNAL; PROLACTIN SECRETING CELL; RECEPTOR DOWN REGULATION;

EID: 0030860528     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80353-0     Document Type: Article

References (58)

1. Amara, S.G., and Kuhar, M.J. (1993). Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 16, 73-93.
2. Barinaga, M., Yamamoto, G., Rivier, C., Vale, W., Evans, R., and Rosenfeld, M.G (1983). Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor. Nature 306, 84-85.
3. Ben-Jonathan, N. (1985). Dopamine: a prolactin-inhibiting hormone. Endocr. Rev. 6, 564-588.
4. Bendotti, C., Servadio, A., Forloni, G., Angeretti, N., and Samanin, R. (1990). Increased tryptophan hydroxylase mRNAin raphe serotoninergic neurons spared by 5,7-dihydroxytryptamine. Mol. Brain Res. 8, 343-348.
5. Billestrup, N., Swanson, L.W., and Vale, W. (1986). Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proc. Natl. Acad. Sci. USA 83, 6854-6857.
6. Bjorklund, A., Moore, R.Y., Nobin, A., and Stenevi, U. (1973). The organization of tubero-hypophysial and reticulo-infundibular catecholamine neuron systems in the rat brain. Brain Res. 51, 171-191.
7. Bodner, M., and Karin, M. (1987). A pituitary-specific trans-acting factor can stimulate transcription from the growth hormone promoter in extracts of non-expressing cells. Cell 50, 267-275.
8. Borgundvaag, B., Kudlow, J.E., Mueller, S.G., and George, R.G. (1992). Dopamine receptor activation inhibits estrogen-stimulated transforming growth factor gene expression and growth in anterior pituitary, but not in uterus. Endocrinology 130, 3453-3458.
9. Borrelli, E., Sawchenko, P.E., and Evans, R.M. (1992). Pituitary hyperplasia induced by ectopic expression of nerve growth factor. Proc. Natl. Acad. Sci. USA 89, 2764-2768.
10. Caron, M.G., Beaulieu, M., Raymond, V., Gagné, B., Drouin, J., Lefkowitz, R.J., and Labrie, F. (1978). Dopaminergic receptors in the anterior pituitary gland. J. Biol. Chem. 253, 2244-2253.
11. Castrillo, J.L., Bodner, M., and Karin, M. (1989). Purification of growth hormone-specific transcription factor GHF-1 containing homeobox. Science 243, 814-817.
12. Castrillo, J.L., Theill, L.E., and Karin, M. (1991). Function of the homeodomain protein GHF1 in pituitary cell proliferation. Science 253, 197-199.
13. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
14. Chomczynski, P., Downs, T.R., and Frohman, L.A. (1988). Feedback regulation of growth hormone (GH)-releasing hormone gene expression by GH in the rat hypothalamus. Mol. Endocrinol. 2, 236-241.
15. 2 dopamine receptor in the intermediate lobe of the rat pituitary gland: a review. Neuroendocrinology 35, 217-224.
16. Cunnah, D., and Besser, M. (1991). Management of prolactinomas. Clin. Endocrinol. 34, 231-235.
17. Dollé, P., Castrillo, J.L., Theill, L.E., Deerinck, T., Ellisman, M., and Karin, M. (1990). Expression of GHF-1 protein in mouse pituitaries correlates both temporally and spatially with the onset of growth hormone gene activity. Cell 60, 809-820.
18. Elsholtz, H.P., Lew, A.M., Albert, P.R., and Sundmark, V.C. (1991). Inhibitory control of prolactin and Pit-1/GHF1 gene promoters by dopamine. Proc. Natl. Acad. Sci. USA 266, 22919-22925.
19. 2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. Mol. Pharmacol. 53, 576-584.
20. Fodor, M., Csaba, Z., Kordon, C., and Epelbaum, J. (1994). Growth hormone-releasing hormone, somatostatin, galanin and beta-endorphin afferents to the hypothalamic periventricular nucleus. J. Chem. Neuroanat. 8, 61-73.
21. Fracker, P.J., and Speck, J.C. (1978). Protein and cell iodinations with a sparingly soluble chloramine, 1,3,4,6-tetrachloro-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80, 849-857.
22. Frohman, L.A., Downs, T.R., and Chomczynski, P. (1992). Regulation of growth hormone secretion. Front. Neuroendocrinol. 13, 344-405.
23. Fulroth, R., Phillips, B., and Durand, D.J. (1989). Perinatal outcome of infants exposed to cocaine and/or heroin in utero. Am. J. Dis. Child. 143, 905-910.
24. Fumagalli, F., Jones, S.R., Caron, M.G., Seidler, F.J., and Slotkin, T.A. (1996). Expression of mRNAcoding for the serotonin transporter in aged vs. young brain: differential effects of glucocorticoids. Brain Res. 719, 225-228.
25. Garris, P.A., and Ben-Jonathan, N. (1991). Effects of reuptake inhibitors on dopamine release from the stalk-median eminence and posterior pituitary in vitro. Brain Res. 556, 123-129.
26. Giros, B., and Caron, M.G. (1993). Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14, 43-49.
27. Giros, B., Jaber, M., Jones, S.R., Wightmann, R.M., and Caron, M.G. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
28. Gluckmann, P.D., Grumbach, M.M., and Kaplan, S.L. (1981). The neuroendocrine regulation and function of growth hormone and prolactin in the mammalian fetus. Endocr. Rev. 2, 363-395.
29. Guillemin, R., Brazeau, P., Bohlen, P., Esch, F., Ling, N., and Wehrenberg, W.B. (1982). Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 218, 585-587.
30. 2 receptors. Psychopharmacology 103, 6-18.
31. Ingraham, H.A., Chen, R., Mangalam, H.J., Elsholtz, H.P., Flynn, S.E., Lin, C.R., Simmons, D.M., Swanson, L., and Rosenfeld, M.G. (1988). A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55, 519-529.
32. Kobrin, M.S., Asa, S.C., Samsoandoor, J., and Kudlow, J.L. (1987). α-Transforming growth factor in the bovine anterior pituitary gland: secretion bydispersed cells and immunohystochemical localization. Endocrinology 121, 1412-1416.
33. Li, S., Crenshaw E.B. III, Rawson, E.J., Simmons, D.M., Swanson, L.W., and Rosenfeld, M.G. (1990). Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347, 528-533.
34. Lin, S.C., Lin, C.R., Gukovsky, I., Lusis, A.J., Sawchenko, P.E., and Rosenfeld, M.G. (1993). Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature 364, 208-213.
35. Mangalam, H.J., Albert, V.R., Ingraham, H.A., Kapiloff, M., Wilson, L., Nelson, C., Elsholtz, H., and Rosenfeld, M.G. (1989). A pituitary POU domain protein, Pit-1/GHF1, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev. 3, 946-958.
36. McAndrew, J., Paterson, A.J., Asa, S.L., McCarthy, K.J., and Kudlow, J.E. (1995). Targeting of transforming growth factor-α expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 136, 4479-4488.
37. Meister, B., and Elde, R. (1993). Dopamine transporter mRNA in neurons of the rat hypothalamus. Mol. Neuroendcrinol. 58, 388-395.
38. Missale, C., Boroni, F., Frassine, M., Caruso, A., and Spano, P.F. (1995). Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro. Endocrinology 136, 1205-1213.
39. Missale, C., Boroni, F., Sigala, S., Buriani, A., Fabris, M., Leon, A., Dal Toso, R., and Spano, P.F. (1996). Nerve growth factor in the anterior pituitary: localization in lactotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism. Proc. Natl. Acad. Sci. USA 93, 4240-4245.
40. Morel, G., Ouhtit, A., and Kelly, P.A., (1994).Prolactin receptor immunoreactivity in rat anterior pituitary. Neuroendocrinology 59, 78-84.
41. Muller, E.E. (1987). Neural control of somatotropic function. Physiol. Rev. 67, 962-1053.
42. Nelson, C., Albert, V.R., Elsholtz, H.P., Lu, L.W., and Rosenfeld, M.G. (1988). Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science 239, 1400-1404.
43. Osamura, R.Y., and Watanabe, K. (1985). Histogenesis of the cells of the anterior pituitary and intermediate lobes of human pituitary glands: immunohistochemical studies. Int. Rev. Cytol. 95, 103-129.
44. Patterson, J.C., and Childs, G.V. (1994). Nerve growth factor and its receptors in the anterior pituitary. Endocrinology 135, 1689-1696.
45. Pfaffle, R.W., DiMattia, G.E., Parks, J.S., Brown, M.R., Wit, J.M., Jansen, M., Van der Nat, H., Van der Brande, J.L., Rosenfeld, G.M., and Ingraham, H.A. (1992). Mutation of the POU-specific domain of Pit-1/GHF1 and hypopituitarism without pituitary hypoplasia. Science 257, 1118-1121.
46. Radovick, S., Nations, M., Du, Y., Berg, L.A., Weintraub, B.D., and Wondisford, F.E. (1992). A mutation in the POU-homeodomain of Pit-1/GHF1 responsible for combined pituitary hormone deficiency. Science 257, 1115-1118.
47. Rattray, M., Wotherspoon, G., Savery, D., Baldessari, S., Marden, C., Priestley, J.V., and Bendotti, C. (1994). Chronic d-fenfluramine decreases serotonin transporter messenger RNA expression in dorsal raphe nucleus. Eur. J. Pharmacol. Mol. Pharmacol. 268, 439-442.
48. Rivier, J., Spiess, J., Thorner, M., and Vale, W. (1982). Characterization of a growth hormone-releasing factor from a human pancreatic islet tumor. Nature 300, 276-279.
49. Saiardi, A., Bozzi, Y., Baik, J.-H., and Borrelli, E. (1997). Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron 19, this issue, 19, 115-126.
50. Sarkar, D.K, Gottschall, P.E., and Meites, J. (1982). Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting pituitary tumors. Science 218, 684-686.
51. Sawchenko, P.E., Swanson, L.W., Rivier, J., and Vale, W.W. (1985). The distribution of GHRH immunoreactivity in the central nervous system of the rat: an immunohistochemical study using antisera directed against rat hypothalamic GHRH. J. Comp. Neurol. 237, 100-115.
52. Smith, R.G., Pong, S.S., Hickey, G., Jacks, T., Cheng, K., Leonard, R., Cohen, C.J., Arena, J.P., Chang, C.H., Drisko, J., Wyvratt, M., Fisher, M., Naragund, R., and Patchett, A. (1996). Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Recent Prog. Horm. Res. 51, 261-285.
53. Sornson, M.W., Wu, W., Dasen, J.S., Flynn, S.E., Norman, D.J., O'Connell, S.M., Gukovsky, I., Carriere, C., Ryan, A.K., Miller, A.P., Zuo, L., Gleiberman, A.S., Andersen, B., Beamer, W.G., and Rosenfeld, M.G. (1996). Pituitary lineage determination by the prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384, 327-333.
54. Stack, J., and Surprenant, A. (1991). Dopamine actions on calcium currents, potassium currents and hormone release in rat melanotrophs. J. Physiol. 493, 37-58.
55. Suhr, S.T., Rahal, J.O., and Mayo, K.E. (1989). Mouse growth hormone-releasing hormone: Precursor structure and expression in brain and placenta. Mol. Endocrinol. 3, 1693-1700.
56. Voss, J.W., and Rosenfeld, M.G. (1992). Anterior pituitary development: short tales from dwarf mice. Cell 70, 527-530.
57. Wass, J.A. (1983). Growth hormone neuroregulation and the clinical relevance of somatostatin. Clin. Endocrinol. Metab. 12, 695-724.
58. Yamauchi, N., Shibasaki, T., Ling, N., and Demura, H. (1991). In vitro release of growth hormone-releasing factor (GRF) from the hypothalamus: somatostatin inhibits GRF release. Regul. Pept. 33, 71-78.